
Vogisa 0.3mg Tablet MD
Marketer
Ablus Pharma
Salt Composition
Voglibose (0.3mg)
Overview Vogisa 0.3mg Tablet MD
Diabexa 0.3mg tablets are indicated for managing type 2 diabetes. This medication helps regulate postprandial hyperglycemia (high blood sugar after meals) when dietary modifications and other antidiabetic agents prove insufficient. Diabexa 0.3mg tablets should be administered immediately before meals. Dosage and frequency are determined by your physician to optimize glycemic control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood glucose, potentially causing severe complications such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan incorporating diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported adverse effects include abdominal discomfort (flatulence, pain), appetite changes, bowel irregularities (constipation, diarrhea), and these should be reported to your physician if persistent or concerning. Diabexa 0.3mg tablets alone do not typically induce hypoglycemia (low blood sugar). However, concurrent use with other antidiabetic medications, especially insulin or sulfonylureas, increases this risk. Hypoglycemic episodes require treatment with pure glucose; sucrose (table sugar) is ineffective. Prior to initiating therapy, disclose any liver or kidney disease. This medicine is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating individuals should seek medical advice. Inform your physician of all concurrent medications to ensure safe usage. Limit alcohol consumption, as it may potentiate hypoglycemia.
Major Benefits of Vogisa 0.3mg Tablet MD:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Vogisa 0.3mg Tablet MD should be taken on an empty stomach.
Common Side effects of Vogisa 0.3mg Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogisa 0.3mg Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Consume the Vogisa 0.3mg Tablet MD on an empty stomach.
How Vogisa 0.3mg Tablet MD works:
Vogisa 0.3mg Tablet MD is an antidiabetic medication that works by suppressing the activity of intestinal enzymes which digest complex carbohydrates into simple sugars like glucose. This action helps to control postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogisa 0.3mg Tablet MD and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vogisa 0.3mg Tablet MD during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Vogisa 0.3mg Tablet MD while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vogisa 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Vogisa 0.3mg Tablet MD cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vogisa 0.3mg Tablet MD. Dosage modification for Vogisa 0.3mg Tablet MD may be necessary; physician consultation is advised.
What if you forget to take Vogisa 0.3mg Tablet MD :
Omit any missed Vogisa 0.3mg Tablet MD dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Vogisa 0.3mg Tablet MD
| Label | Value |
|---|---|
| Type of Compound | Valiolamine-based compound |
| Addictive | None. |
| Medication Category | Medication for diabetes |
| Mechanism of Action | Agents that inhibit alpha-glucosidase |
